The case, filed on January 8, 2026 as Case No. 2:26-cv-01542, brings three insulin makers – Eli Lilly & Company, Novo Nordisk Inc., and Sanofi-Aventis US LLC – to Cigna Health & Life Insurance Company, Evernorth Health, Inc. (formerly Express Scripts Holding Company) and affiliates, CVS Health Corporation and its CareMark pharmacy benefits. Management pulls along with operations. Subsidiaries, and UnitedHealth Group, Inc. Through Optum and OptumRx, among others. New Haven, which runs self-insured health plans for its employees and eligible retirees, says it is paying artificially inflated prices for insulin and other diabetes drugs as a result.
New Haven sues Cigna, CVS Health, UnitedHealth over insulin pricing scheme & more related News Here
